HuagongsheHuagongshe Chemistry Print Report · For research reference only
2-Chlorobenzimidazole → n-(Benzimidazol-2-yl)-5-bromo-1-indanylamine
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 2-Chlorobenzimidazole | HCID 78572 | — |
| Reactant | 5-bromo-2,3-dihydro-1H-inden-1-amine | HCID 22228388 | — |
| Product | n-(Benzimidazol-2-yl)-5-bromo-1-indanylamine | HCID 11624041 | — |
Reaction Steps
The title compound was prepared from 2-chlorobenzimidazole and racemic 1-amino-5-bromoindane (prepared by Procedure B from 5-bromo-1-indanone) by Procedure A (30 min at 170° C.). The product was isolated by preparative LCMS to give the title compound as the free base and as a mixture of enantiomers (white solid, mp 242-243° C.). MS(ES+) m/z 328 ([M+1]+, 100). 1NMR (DMSO-d6) δ 1.92 (m, 1H), 2.50 (m, 1H), 2.83 (m, 1H), 2.95 (m, 1H), 5.35 (m, 1H), 6.82-7.02 (m, 3H), 7.12-7.35 (m, 4H), 7.46 (s, 1H), 10.7 (s, 1H).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07737167B2 |
| Source dataset | uspto-grants-2010_06 |
| ORD ID | ord-1af200ca71724ded997ce2ce2a9d94a6 |
| Source note | uspto-grants-2010_06 |